InsP3 Signaling in Apicomplexan Parasites

dc.contributor.authorGarcia, Celia R.S.
dc.contributor.authorAlves, Eduardo
dc.contributor.authorPereira, Pedro H.S.
dc.contributor.authorBartlett, Paula
dc.contributor.authorThomas, Andrew
dc.contributor.authorMikoshiba, Katsuhiko
dc.contributor.authorPlattner, Helmut
dc.contributor.authorSibley, L. David
dc.date.accessioned2017-04-04T12:35:49Z
dc.date.available2017-04-04T12:35:49Z
dc.date.issued2017-01-30
dc.description.abstractPhosphoinositides (PIs) and their derivatives are essential cellular components that form the building blocks for cell membranes and regulate numerous cell functions. Specifically, the ability to generate myo-inositol 1,4,5-trisphosphate (InsP3) via phospholipase C (PLC) dependent hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) to InsP3 and diacylglycerol (DAG) initiates intracellular calcium signaling events representing a fundamental signaling mechanism dependent on PIs. InsP3 produced by PI turnover as a second messenger causes intracellular calcium release, especially from endoplasmic reticulum, by binding to the InsP3 receptor (InsP3R). Various PIs and the enzymes, such as phosphatidylinositol synthase and phosphatidylinositol 4-kinase, necessary for their turnover have been characterized in Apicomplexa, a large phylum of mostly commensal organisms that also includes several clinically relevant parasites. However, InsP3Rs have not been identified in genomes of apicomplexans, despite evidence that these parasites produce InsP3 that mediates intracellular Ca2+ signaling. Evidence to supporting IP3-dependent signaling cascades in apicomplexans suggests that they may harbor a primitive or non-canonical InsP3R. Understanding these pathways may be informative about early branching eukaryotes, where such signaling pathways also diverge from animal systems, thus identifying potential novel and essential targets for therapeutic intervention.eng
dc.description.versionpublishedeng
dc.identifier.doi10.2174/1568026617666170130121042eng
dc.identifier.urihttps://kops.uni-konstanz.de/handle/123456789/38306
dc.language.isoengeng
dc.subjectCalcium signaling, InsP3 Signaling, Apicomplexan Parasiteseng
dc.subject.ddc570eng
dc.titleInsP3 Signaling in Apicomplexan Parasiteseng
dc.typeJOURNAL_ARTICLEeng
dspace.entity.typePublication
kops.citation.bibtex
@article{Garcia2017-01-30InsP3-38306,
  year={2017},
  doi={10.2174/1568026617666170130121042},
  title={InsP3 Signaling in Apicomplexan Parasites},
  number={19},
  volume={17},
  issn={1568-0266},
  journal={Current Topics in Medicinal Chemistry},
  pages={2158--2165},
  author={Garcia, Celia R.S. and Alves, Eduardo and Pereira, Pedro H.S. and Bartlett, Paula and Thomas, Andrew and Mikoshiba, Katsuhiko and Plattner, Helmut and Sibley, L. David}
}
kops.citation.iso690GARCIA, Celia R.S., Eduardo ALVES, Pedro H.S. PEREIRA, Paula BARTLETT, Andrew THOMAS, Katsuhiko MIKOSHIBA, Helmut PLATTNER, L. David SIBLEY, 2017. InsP3 Signaling in Apicomplexan Parasites. In: Current Topics in Medicinal Chemistry. 2017, 17(19), pp. 2158-2165. ISSN 1568-0266. eISSN 1873-4294. Available under: doi: 10.2174/1568026617666170130121042deu
kops.citation.iso690GARCIA, Celia R.S., Eduardo ALVES, Pedro H.S. PEREIRA, Paula BARTLETT, Andrew THOMAS, Katsuhiko MIKOSHIBA, Helmut PLATTNER, L. David SIBLEY, 2017. InsP3 Signaling in Apicomplexan Parasites. In: Current Topics in Medicinal Chemistry. 2017, 17(19), pp. 2158-2165. ISSN 1568-0266. eISSN 1873-4294. Available under: doi: 10.2174/1568026617666170130121042eng
kops.citation.rdf
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/38306">
    <dc:language>eng</dc:language>
    <dc:creator>Alves, Eduardo</dc:creator>
    <dc:creator>Pereira, Pedro H.S.</dc:creator>
    <dc:contributor>Mikoshiba, Katsuhiko</dc:contributor>
    <dcterms:title>InsP3 Signaling in Apicomplexan Parasites</dcterms:title>
    <dc:contributor>Bartlett, Paula</dc:contributor>
    <dc:contributor>Pereira, Pedro H.S.</dc:contributor>
    <dcterms:issued>2017-01-30</dcterms:issued>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dc:creator>Plattner, Helmut</dc:creator>
    <dc:creator>Bartlett, Paula</dc:creator>
    <dcterms:abstract xml:lang="eng">Phosphoinositides (PIs) and their derivatives are essential cellular components that form the building blocks for cell membranes and regulate numerous cell functions. Specifically, the ability to generate myo-inositol 1,4,5-trisphosphate (InsP3) via phospholipase C (PLC) dependent hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) to InsP3 and diacylglycerol (DAG) initiates intracellular calcium signaling events representing a fundamental signaling mechanism dependent on PIs. InsP3 produced by PI turnover as a second messenger causes intracellular calcium release, especially from endoplasmic reticulum, by binding to the InsP3 receptor (InsP3R). Various PIs and the enzymes, such as phosphatidylinositol synthase and phosphatidylinositol 4-kinase, necessary for their turnover have been characterized in Apicomplexa, a large phylum of mostly commensal organisms that also includes several clinically relevant parasites. However, InsP3Rs have not been identified in genomes of apicomplexans, despite evidence that these parasites produce InsP3 that mediates intracellular Ca2+ signaling. Evidence to supporting IP3-dependent signaling cascades in apicomplexans suggests that they may harbor a primitive or non-canonical InsP3R. Understanding these pathways may be informative about early branching eukaryotes, where such signaling pathways also diverge from animal systems, thus identifying potential novel and essential targets for therapeutic intervention.</dcterms:abstract>
    <dc:contributor>Alves, Eduardo</dc:contributor>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:contributor>Thomas, Andrew</dc:contributor>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-04-04T12:35:49Z</dc:date>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-04-04T12:35:49Z</dcterms:available>
    <dc:contributor>Plattner, Helmut</dc:contributor>
    <dc:creator>Mikoshiba, Katsuhiko</dc:creator>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/38306"/>
    <dc:contributor>Sibley, L. David</dc:contributor>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:contributor>Garcia, Celia R.S.</dc:contributor>
    <dc:creator>Thomas, Andrew</dc:creator>
    <dc:creator>Sibley, L. David</dc:creator>
    <dc:creator>Garcia, Celia R.S.</dc:creator>
  </rdf:Description>
</rdf:RDF>
kops.sourcefieldCurrent Topics in Medicinal Chemistry. 2017, <b>17</b>(19), pp. 2158-2165. ISSN 1568-0266. eISSN 1873-4294. Available under: doi: 10.2174/1568026617666170130121042deu
kops.sourcefield.plainCurrent Topics in Medicinal Chemistry. 2017, 17(19), pp. 2158-2165. ISSN 1568-0266. eISSN 1873-4294. Available under: doi: 10.2174/1568026617666170130121042deu
kops.sourcefield.plainCurrent Topics in Medicinal Chemistry. 2017, 17(19), pp. 2158-2165. ISSN 1568-0266. eISSN 1873-4294. Available under: doi: 10.2174/1568026617666170130121042eng
relation.isAuthorOfPublicationf99b668b-482b-49ec-8891-bc63a63a9ebb
relation.isAuthorOfPublication.latestForDiscoveryf99b668b-482b-49ec-8891-bc63a63a9ebb
source.bibliographicInfo.fromPage2158
source.bibliographicInfo.issue19
source.bibliographicInfo.toPage2165
source.bibliographicInfo.volume17
source.identifier.eissn1873-4294eng
source.identifier.issn1568-0266eng
source.periodicalTitleCurrent Topics in Medicinal Chemistryeng

Dateien